Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | ABL1 |
Variant | Y245C |
Impact List | missense |
Protein Effect | gain of function |
Gene Variant Descriptions | ABL1 Y245C (corresponds to Y226C in the canonical isoform) does not lie within any known functional domains of the Abl1 protein (UniProt.org). Y226C confers a gain of function to the Abl1 protein as demonstrated by increased STAT5 phosphorylation and elevated total phosphotyrosine levels in cultured cells (PMID: 28288113). |
Associated Drug Resistance | |
Category Variants Paths |
ABL1 mutant ABL1 act mut ABL1 Y245C |
Transcript | NM_007313.3 |
gDNA | chr9:g.130862890A>G |
cDNA | c.734A>G |
Protein | p.Y245C |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
NM_007313.2 | chr9:g.130862890A>G | c.734A>G | p.Y245C | RefSeq | GRCh38/hg38 |
NM_007313.3 | chr9:g.130862890A>G | c.734A>G | p.Y245C | RefSeq | GRCh38/hg38 |
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|